, including India’s Ranbaxy Laboratories Ltd, which had faced similar charges, paid penalties to settle the problems. Such companies may also have to sign consent decrees to resolve the shortcomings with much longer resolution time and thereby revenue loss for several years.` For full details..
7.53 PM Dec 5th
Source:The Hindu BusinessLine - Ranbaxy Laboratories sustained its firm undertone on the NSE by close on Monday. At 3.20 p.m. it was trading at Rs 449 or 6.44 per cent higher than Friday`s close of Rs 421.85. (This article was published on December 2, 2013)
6.56 PM Dec 2nd
Source:The Hindu BusinessLine - Ranbaxy Laboratories was the top gainer on the NSE in Monday morning trade. At 11.20 a.m. it was trading at Rs 445.90 or 5.70 per cent higher than its Friday close of Rs 421.85. (This article was published on December 2, 2013)
3.03 PM Dec 2nd
Follow moneycontrol.comFacebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.